DrugPatentWatch Database Preview

TRAZODONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Trazodone Hydrochloride, and when can generic versions of Trazodone Hydrochloride launch?

Trazodone Hydrochloride is a drug marketed by Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurolife Pharma Llc, Fosun Pharma, Mylan, Mylan Pharms Inc, Oxford Pharms, Pliva, Quantum Pharmics, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent Pharms Ltd, Usl Pharma, Watson Labs, and Zydus Pharms Usa Inc. and is included in twenty-eight NDAs.

The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

Summary for TRAZODONE HYDROCHLORIDE

US Patents:	0
Applicants:	19
NDAs:	28
Suppliers / Packagers:	44
Bulk Api Vendors:	84
Clinical Trials:	45
Patent Applications:	1,181
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for TRAZODONE HYDROCHLORIDE
DailyMed Link:	TRAZODONE HYDROCHLORIDE at DailyMed

Pharmacology for TRAZODONE HYDROCHLORIDE

Drug Class

Serotonin Reuptake Inhibitor

Medical Subject Heading (MeSH) Categories for TRAZODONE HYDROCHLORIDE

Anti-Anxiety Agents

Antidepressive Agents, Second-Generation

Serotonin Uptake Inhibitors

Synonyms for TRAZODONE HYDROCHLORIDE

1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-, monohydrochloride

1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride

1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride

1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one,2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-,hydrochloride (1:1)

1,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride

19666-36-5

2-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one HCl

2-(3-(4-(3-Chlorophenyl)piperazin-1-y)propyl)-1,2,4-triazolo(4,3-a)pyridine-3(2H)-one hydrochloride

2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride

2-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2H)-one hydrochloride

2-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2H)-one monohydrochloride

2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-

2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride

2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride

2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride

2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride

2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one monohydrochloride

2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-2H,3H-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride

2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride

2-{3-[4-(3-chlorophenyl)piperazinyl]propyl}-4-hydro-1,2,4-triazolino[4,3-a]pyr idin-3-one, chloride

25332-39-2

332T392

4CA-1276

6E8ZO8LRNM

A813950

A817789

AB2000676

AC-6779

AC1L1Y2P

AC1Q3BFE

AF 1161

AF-1161

AK-51734

AKOS015897762

AN-9680

Apo-Trazodone

Azona

BC215367

Bimaran

C19H22ClN5O.HCl

C19H23Cl2N5O

CAS-25332-39-2

CCG-40299

CHEBI:9655

CHEMBL1200798

CPD000058520

CS-2592

CT0209

CTK4F5497

D00820

Desyrel

Desyrel (TN)

Devidon

DSSTox_CID_24626

DSSTox_GSID_44626

DSSTox_RID_80361

DTXSID8044626

EINECS 243-216-2

EINECS 246-855-5

EU-0101159

FT-0659024

HE067225

HMS1568L06

HMS1922G09

HSDB 7048

HY-B0478

I13-027

J-015941

J10153

Jsp005028

K-6661

KB-831

KS-00000ZWU

KS-5100

LP01159

LS-156736

MCULE-3098459714

MFCD00079603

MLS000069698

MLS000758230

MLS001148260

MLS001424009

Molipaxin

MolPort-001-684-664

NC00046

NCGC00016035-02

NCGC00016035-13

NCGC00094420-01

NCGC00094420-02

NCGC00094420-03

NCGC00094420-04

NCGC00256807-01

NCGC00261844-01

NSC 292811

NSC-292811

NSC-758393

NSC292811

NSC758393

Oleptro

Opera_ID_850

Pharmakon1600-01503121

Pragmazone

Prestwick_478

PubChem15888

s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-, monohydrochloride

s-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-,monohydrochloride

S-Triazolo[4, 2-[3-[4-(m-chlorophenyl)-1-piperazinyl]propyl]-, monohydrochloride

S-Trizolo[4, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, hydrochloride

S2582

SAM001247045

SC-16187

SCHEMBL61754

SMR000058520

SPECTRUM1503121

ST2407780

ST51015149

T 6154

Thombran

Tombran

Tox21_110286

Tox21_110286_1

Tox21_302685

Tox21_501159

Trazodone (hydrochloride)

Trazodone Hcl

Trazodone hydrochloride (Desyrel)

Trazodone hydrochloride (JAN/USP)

Trazodone hydrochloride [USAN:JAN]

Trazodone hydrochloride [USAN:USP:JAN]

Trazodone Hydrochloride 1.0 mg/ml in Methanol (as free base)

Trazodone hydrochloride, >=99% (HPLC), powder

Trazodone hydrochloride, United States Pharmacopeia (USP) Reference Standard

Tritico

Triticum

UNII-6E8ZO8LRNM

VA11904

WLN: T56 ANVNNJ C3- AT6N DNTJ DR CG &GH

Z1550675462

US Patents and Regulatory Information for TRAZODONE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa Inc	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	205253-001	Oct 10, 2017	AB	RX	No	No
Torrent Pharms Ltd	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	202180-002	Nov 27, 2013	AB	RX	No	No
Teva	TRAZODONE HYDROCHLORIDE	trazodone hydrochloride	TABLET;ORAL	074357-001	Apr 30, 1997		DISCN	No	No